DarrenKeithMcGuireMD

PubMed

• Putting More Weight on Obesity Trials in Heart Failure.
  Naveed Sattar, G Michael Felker, Carolyn S P Lam, Harriette G C Van Spall, Josephine Harrington, James L Januzzi, Neha J Pagidipati, Ambarish Pandey, Darren K McGuire> ;Current Heart Failure Reports. 2024 Apr 15
• Worth Their Weight? An Update on New and Emerging Pharmacologic Agents for Obesity and Their Potential Role for Persons with Cardiac Conditions.
  G Michael Felker, Carolyn S P Lam, Naveed Sattar, Harriette G C Van Spall, Subodh Verma, Josephine Harrington, James L Januzzi, Ildiko Lingvay, Neha J Pagidipati, Darr...> ;Current Cardiology Reports. 2024 Mar 1
• PREVENT Equations: A New Era in Cardiovascular Disease Risk Assessment.
  Alexander C Razavi, Payal Kohli, Darren K McGuire, Seth S Martin, Tamar S Polonsky, John W McEvoy, Seamus P Whelton, Roger S Blumenthal> ;Circulation. Cardiovascular Quality and Outcomes. 2024 Apr 1
• Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes: Contemporary Understanding With Greater Emphasis on Excess Adiposity.
  Naveed Sattar, Calum Presslie, Martin K Rutter, Darren K McGuire> ;Diabetes Care. 2024 Apr 1
• 1 citations
  Vascular Regenerative Cell Deficiencies in South Asian Adults.
  Krishnaraj, A., Bakbak, E., Teoh, H., Pan, Y., Firoz, I., Pandey, A., Terenzi, D., Verma, R., Bari, B., Bakbak, A., Kunjummar, S., Yanagawa, B., Connelly, K., Mazer, C...> ;Journal of the American College of Cardiology. 2024 Feb 20
• 3 citations
  Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure.
  James, S., Erlinge, D., Storey, R., McGuire, D., de Belder, M., Eriksson, N., Andersen, K., Austin, D., Arefalk, G., Carrick, D., Hofmann, R., Hoole, S., Jones, D., Le...> ;NEJM Evidence. 2024 Feb 1
• 1 citations
  Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical Trials.
  Marx, N., Johansen, O., Cooper, M., Alexander, J., Wanner, C., Espeland, M., Mattheus, M., Schnaidt, S., Perkovic, V., Gollop, N., Kolkailah, A., Rosenstock, J., Toto,...> ;JAMA Cardiology. 2024 Feb 1
• 1 citations
  Natriuretic peptides, body mass index and heart failure risk: Pooled analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61.
  Siddharth M Patel, David A Morrow, Andrea Bellavia, David D Berg, Deepak L Bhatt, Petr Jarolim, Lawrence A Leiter, Darren K McGuire, Itamar Raz, P Gabriel Steg, John P...> ;European Journal of Heart Failure. 2024 Feb 1
• 1 citations
  Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1c.
  Rahul Aggarwal, Deepak L Bhatt, Michael Szarek, Christopher P Cannon, Darren K McGuire, Silvio E Inzucchi, Renato D Lopes, Michael J Davies, Phillip Banks, Bertram Pit...> ;Journal of the American College of Cardiology. 2023 Nov 7
• Risk Factors for and Risk of Peripheral Artery Disease in Swedish Individuals With Type 2 Diabetes: A Nationwide Register-Based Study.
  Tarik Avdic, Hanne K Carlsen, Rikard Isaksson, Soffia Gudbjörnsdottir, Zacharias Mandalenakis, Stefan Franzén, Naveed Sattar, Joshua A Beckman, Darren K McGuire, Björn...> ;Diabetes Care. 2024 Jan 1
• Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial.
  Ambarish Pandey, Ahmed A Kolkailah, Francesco Cosentino, Christopher P Cannon, Robert C Frederich, David Z I Cherney, Samuel Dagogo-Jack, Richard E Pratley, Nilo B Cat...> ;European Heart Journal. 2023 Dec 21
• Managing Obesity in Heart Failure: A Chance to Tip the Scales?
  Josephine Harrington, G Michael Felker, Ildiko Lingvay, Neha J Pagidipati, Ambarish Pandey, Darren K McGuire> ;JACC. Heart Failure. 2024 Jan 1
• 13 citations
  Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPA...
  Stephen J Nicholls, Deepak L Bhatt, John B Buse, Stefano Del Prato, Steven E Kahn, A Michael Lincoff, Darren K McGuire, Michael A Nauck, Steven E Nissen, Naveed Sattar...> ;American Heart Journal. 2024 Jan 1
• 5 citations
  Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction.
  Stefan James, David Erlinge, Robert F Storey, Darren K McGuire, Mark de Belder, Ida Björkgren, Peter A Johansson, Anna Maria Langkilde, Wilhelm Ridderstråle, Ehsan Par...> ;American Heart Journal. 2023 Dec 1
• 6 citations
  Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF.
  Bertram Pitt, Deepak L Bhatt, Michael Szarek, Christopher P Cannon, Lawrence A Leiter, Darren K McGuire, Julia B Lewis, Matthew C Riddle, Adriaan A Voors, Marco Metra,...> ;JACC. Heart Failure. 2023 Aug 1
• 12 citations
  Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations.
  Muhammad Shariq Usman, Tariq Jamal Siddiqi, Stefan D Anker, George L Bakris, Deepak L Bhatt, Gerasimos Filippatos, Gregg C Fonarow, Stephen J Greene, James L Januzzi J...> ;Journal of the American College of Cardiology. 2023 Jun 27
• 2 citations
  Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials.
  Muhammad Shahzeb Khan, Muhammad Shariq Usman, Khawaja M Talha, Harriette G C Van Spall, Stephen J Greene, Muthiah Vaduganathan, Sadiya S Khan, Nicholas L Mills, Ziad A...> ;European Heart Journal. 2023 Jun 1
• 7 citations
  Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRE...
  Michael E Nassif, Sheryl L Windsor, Kensey Gosch, Barry A Borlaug, Mansoor Husain, Silvio E Inzucchi, Dalane W Kitzman, Darren K McGuire, Bertram Pitt, Benjamin M Scir...> ;Circulation. Heart Failure. 2023 Jul 1
• Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (...
  David Z I Cherney, Francesco Cosentino, Darren K McGuire, Ahmed A Kolkailah, Samuel Dagogo-Jack, Richard E Pratley, Robert Frederich, Mario Maldonado, Chih-Chin Liu, C...> ;Kidney International Reports. 2023 Apr 1
• 4 citations
  Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States.
  Callahan Clark, Arya Aminorroaya, Lian Chen, Mengni Liu, Abraham Reddy, Samuel Amodeo, Marc A Suchard, Darren K McGuire, Zhenqiu Lin, Silvio Inzucchi, Rohan Khera, Ara...> ;The American Journal of Cardiology. 2023 Jun 1
• 6 citations
  Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial.
  Meir Schechter, Stephen D Wiviott, Itamar Raz, Erica L Goodrich, Aliza Rozenberg, Ilan Yanuv, Sabina A Murphy, Thomas A Zelniker, Martin Fredriksson, Peter A Johansson...> ;The Lancet. Diabetes & Endocrinology. 2023 Apr 1
• 4 citations
  Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes: A Secondary Analysis of the DECLARE-TIMI 58 Trial.
  Thomas A Zelniker, Stephen D Wiviott, Ofri Mosenzon, Erica L Goodrich, Petr Jarolim, Avivit Cahn, Deepak L Bhatt, Lawrence A Leiter, Darren K McGuire, John Wilding, Ol...> ;JAMA Cardiology. 2023 May 1
• 3 citations
  Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and design.
  Adam J Nelson, Neha J Pagidipati, Michelle D Kelsey, Maddalena Ardissino, Vanita R Aroda, Matthew A Cavender, Renato D Lopes, Hussein R Al-Khalidi, Rogelio Braceras, T...> ;American Heart Journal. 2023 Feb 1
• 1 citations
  Incident and recurrent hypoglycaemia with linagliptin and glimepiride over a median of 6 years in the CAROLINA cardiovascular outcome trial.
  Julio Rosenstock, Ahmed A Kolkailah, Darren K McGuire, Mark A Espeland, Michaela Mattheus, Egon Pfarr, Søren S Lund, Nikolaus Marx> ;Diabetes, Obesity & Metabolism. 2023 Jun 1
• Effects of once-weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: I...
  Ahmed A Kolkailah, Ildiko Lingvay, Idit Dobrecky-Mery, Alona Aharonovich, Jens-Peter David, Cecilie Holse, Søren Rasmussen, Darren K McGuire> ;Diabetes, Obesity & Metabolism. 2023 Apr 1
• Join now to see all

Journal Articles

• Trends in Hospitalizations for Heart Failure and Ischemic Heart Disease Among US Adults with Diabetes  
  Michael C Honigberg, Ravi B Patel, Javed Butler, Darren K Mcguire, JAMA Cardiology
• Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure  
  Deepak L Bhatt, Darren K Mcguire, Jeffrey M Testani, Pablo Lapuerta, Bertram Pitt, The New England Journal of Medicine
• Association of SGLT2 Inhibitors with Cardiovascular and Kidney Outcomes in Patients with Type 2 Diabetes  
  Darren K Mcguire, Samuel Dagogo-Jack, Urszula Masiukiewicz, JAMA Cardiology
• Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes  
  Samuel Dagogo-Jack, Urszula Masiukiewicz, Robert Frederich, Darren K Mcguire, The New England Journal of Medicine
• Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Cardiovascular Disease  
  Michael C Honigberg, Darren K Mcguire, Muthiah Vaduganathan, JAMA Cardiology
• Improved Time in Range and Glycemic Variability with Sotagliflozin in Combination with Insulin in Adults with Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous ...  
  Jake A Kushner, John B Buse, Satish K Garg, Darren K McGuire, Diabetes Care
• Lower Rates of Cardiovascular Events and Mortality Associated with Liraglutide Use in Patients Treated with Basal Insulin – A DEVOTE Subanalysis (DEVOTE 10)  
  John B Buse, Darren K McGuire, Richard E Pratley, Diabetes, Obesity and Metabolism
• Fasiglifam-Induced Liver Injury in Patients with Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial  
  Darren McGuire, MD, Diabetes Care
• Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes  
  Stephen D Wiviott, Marc S Sabatine, Christian T Ruff, Marc P Bonaca, Deepak L Bhatt, Darren K McGuire, The New England Journal of Medicine
• Heart Failure Epidemiology in Patients with Diabetes Mellitus Without Coronary Heart Disease  
  James L Januzzi, Darren K Mcguire, Javed Butler, Journal of Cardiac Failure
• Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults with Type 2 Diabetes and High Cardiovascular and Renal Risk  
  Steven E Kahn, John H Alexander, Robert D Toto, Darren K McGuire, JAMA
• Relation of Plasma Ceramides to Visceral Adiposity, Insulin Resistance and the Development of Type 2 Diabetes Mellitus: The Dallas Heart Study  
  Ian J Neeland, Darren K McGuire, Shruti Singh, Diabetologia
• Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients  
  Erin A Bohula, Stephen D Wiviott, Benjamin M Scirica, Darren K McGuire, Marc S Sabatine, Marc P Bonaca, Christian T Ruff, Silvio E Inzucchi, The New England Journal of Medicine
• Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients  
  Christina L. Fanola, Darren K. McGuire, Silvio E. Inzucchi, Erin A. Bohula, The New England Journal of Medicine
• Management of Patients with Diabetes and Heart Failure with Reduced Ejection Fraction: An International Comparison  
  James L Januzzi, Mikhail Kosiborod, Frederick A Masoudi, Darren K McGuire, Suzanne V Arnold, Gregg C Fonarow, Diabetes, Obesity and Metabolism
• Sotagliflozin in Combination with Optimized Insulin Therapy in Adults with Type 1 Diabetes: The North American inTandem1 Study  
  Satish K Garg, John B Buse, Jake A Kushner, Darren K McGuire, Diabetes Care
• And Hypoglycemia Reductions at 24 and 52 Weeks with Sotagliflozin in Combination with Insulin in Adults with Type 1 Diabetes: The European inTandem2 Study  
  Jake A Kushner, Darren K McGuire, Diabetes Care
• Long-Term Association of LDL Cholesterol with Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results from the C...  
  Abdullah SM, Defina LF, Leonard D, Barlow C, Radford NB, Willis BL, Rohatgi A, McGuire DK, de Lemos JA, Grundy SM, Berry JD, Khera A, Circulation, 1/1/2018
• Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure Insights from the Diabetes Collaborative Registry (DCR)  
  Arnold SV, Echouffo-Tcheugui J, Lam CSP, Inzucchi SE, Tang F, McGuire DK, Goyal A, Maddox TM, Sperling LS, Fonarow GC, Masoudi FA, Kosiborod M, Am Heart J, 1/1/2018
• Management of patients with diabetes and heart failure with reduced ejection fraction: an international comparison  
  Arnold SV, Yap J, Lam CSP, Tang F, Tay WT, Teng THK, McGuire DK, Januzzi JL, Fonarow GC, Masoudi FA, Kosiborod M, Diabetes Obes Metab, 1/1/2018
• Prevention and Remission of Type 2 Diabetes with Lorcaserin in Overweight and Obese Patients  
  Bohula EA, Scirica BM, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Kanevsky E, Murphy SA, Leiter LA, Dwyer J, Corbalan R, Hamm C, Kaplan L, Nicolau JC, Oude Ophuis T,..., Lancet, 1/1/2018
• Design and Baseline Characteristics of the eValuation of ERTugliflozin effIcacy and Safety Cardiovascular Outcomes Trial (VERTIS-CV)  
  Cannon CP, McGuire DK, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S,Charbonnel B, Shih WJ,Gallo S, Masiukiewicz U, Golm G, Cosentino F, Lauring B, Terra SG, on behalf ..., Am Heart J, 1/1/2018
• Linagliptin Effects on Heart Failure Outcomes in Participants with Type 2 Diabetes at High CV and Renal Risk in CARMELINA( R)  
  McGuire DK, Alexander JH, Johansen OE, Perkovic V, Rosenstock J , Cooper ME, Wanner C, Kahn SE, Toto R, Zinman B, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George J..., Circulation, 1/1/2018
• Relation of Plasma Ceramides to Visceral Adiposity, Insulin Resistance, and the Development of Type 2 Diabetes Mellitus: The Dallas Heart Study  
  Neeland IJ, Singh S, McGuire DK, Vega GL, Roddy T, Reilly DF, Castro-Perez J, Kozlitina J, Scherer PE, Diabetologia, 1/1/2018
• Heart Failure Epidemiology in Patients with Diabetes Mellitus without Coronary Heart Disease: Insights from the Health, Aging, and Body Composition Study  
  Khan H, Anker SD, Januzzi Jr JL, McGuire DK, Sattar N, Woerle HJ, Butler J, J Cardiac Failure, 1/1/2018
• Join now to see all

Books/Book Chapters

• Braunwald's Heart Disease: A textbook of cardiovascular medicine 
  Chapter: Diabetes and the cardiovascular system 
  McGuire DKEditors: Mann DL, Zipes DP, Libby P, Bonow RO.Saunders Elsevier, Philadelphia, PAEdition 10th,2015
• Prevention of Cardiovascular Disease: A Companion to Braunwald's Heart Disease 
  Chapter: Diabetes and Cardiovascular Disease 
  Gore MO, Inzucchi S, McGuire DKEditors: Blumenthal RS, Foody JM, and Wong ND.Saunders, an imprint of Elsvier, Inc., Philadelphia, PAEdition 1st,2011
• Evidence-based Management of Diabetes. 
  Chapter: Hyperglycemia in acute coronary syndromes. 
  Gore MO, Kosiborod M, McGuire DKEditors: Vora J, Buse J.tfm publishing Ltd, Shrewsbury, United Kingdom2011
• Braunwald�s Heart Disease: A textbook of cardiovascular medicine 
  Chapter: Diabetes and the cardiovascular system 
  McGuire DKEditors: Libby P, Bonow RO, Mann DL, Zipes DP.Saunders Elsevier, Philadelphia, PAEdition 9th,2010
• Current Controversies and Changing Practice 
  Chapter: The Cardiovascular Quandary, in Hypoglycemia in Type 2 Diabetes 
  McGuire DKEditors: Henry RR.Royal Society of Medicine Press Limited, London, United Kingdom2010
• Clinical Research: From Proposal to Implementation 
  Chapter: Writing Informed Consent Documents and Obtaining Informed Consent 
  Clark A, Rivera SM, Sheppard D, McGuire DK, McPhaul MJEditors: Michael J. McPhaul and Robert D. Toto.Lippincott Williams & Wilkins, Philadelphia, PAEdition 1st,2010
• Harrison�s Online Textbook of Internal Medicine 
  Chapter: Cardiovascular Considerations for the Use of Thiazolidinedione Medications 
  McGuire DK, Inzucchi SEEditors: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson L, and Loscalzo J.Edition 17th,2009
• Contemporary Endocrinology: Type 2 Diabetes Mellitus: An Evidence-based Approach to Practical Management 
  Chapter: Management of Coronary Artery Disease in Type 2 Diabetes Mellitus 
  Petersen JL, McGuire DKEditors: Feinglos MN and Bethel MA.Humana Press, Totowa, NJ2008
• ACC SAP Version 6 
  Chapter: Risk factors-Diabetes and CHD. 
  McGuire DK, Rutherford JDEditors: Richard P. Lewis.2005
• The Handbook of Diabetes and Cardiovascular Disease. 
  Chapter: Epidemiology of Diabetes and Cardiovascular Disease 
  McGuire DK, Rao SVEditors: Steven P. Marso.Remedica Publishing, London, United Kingdom2003
• The Elderly, Woman, and Patient with Diabetes in Acute Coronary Syndromes: A Companion to Braunwald's Heart Disease. 
  McGuire DK, Newby LK, Biswas M, Hochman JSEditors: Pierre Theroux.Harcourt Health Sciences2003
• New Standards of AMI Care. Part V: Reperfusion of Special Populations. 
  Chapter: Caring for the patient with diabetes and myocardial infarction. 
  Page 13 - 25Califf RM, McGuire DK, Feinglos MAEditors: Califf, RM.Exerpta Medica, Inc, New York, NY1998
• Join now to see all

Abstracts/Posters

• A1C : Glucose management in type 2 diabetes mellitus.
  Goyal A, Kosiborod M, McGuire DK, Garber AJ, American College of Cardiology Foundation Diabetes Self-Assessment Program, Washington, DC, 1/1/2011

Lectures

• Assessment of Omega‐3 Carboxylic Acids in Statin Treated Patients with High Levels of Triglycerides and Low Levels of High Density Lipoprotein Cholesterol: Rationale a... 
  Scientific Sessions 2008, New Orleans, Louisiana, USA
• Assessment of Omega‐3 Carboxylic Acids in Statin Treated Patients with High Levels of Triglycerides and Low Levels of High Density Lipoprotein Cholesterol: Rationale a... 
  Scientific Sessions 2007, Orlando, Florida, USA
• Assessment of Omega‐3 Carboxylic Acids in Statin Treated Patients with High Levels of Triglycerides and Low Levels of High Density Lipoprotein Cholesterol: Rationale a... 
  International Chair on Cardiometabolic Risk, 2nd International Congress on Abdominal Obesity, Buenos
• Assessment of Omega‐3 Carboxylic Acids in Statin Treated Patients with High Levels of Triglycerides and Low Levels of High Density Lipoprotein Cholesterol: Rationale a... 
  American Heart Association, Scientific Sessions 2008, New Orleans, Louisiana, USA
• Assessment of Omega‐3 Carboxylic Acids in Statin Treated Patients with High Levels of Triglycerides and Low Levels of High Density Lipoprotein Cholesterol: Rationale a... 
  American College of Cardiology, 59th Annual Scientific Session & Expo, Atlanta, Georgia, USA
• Assessment of Omega‐3 Carboxylic Acids in Statin Treated Patients with High Levels of Triglycerides and Low Levels of High Density Lipoprotein Cholesterol: Rationale a... 
  American Heart Association, Scientific Sessions 2007, Orlando, Florida, USA
• Assessment of Omega‐3 Carboxylic Acids in Statin Treated Patients with High Levels of Triglycerides and Low Levels of High Density Lipoprotein Cholesterol: Rationale a... 
  59th Annual Scientific Session & Expo, Atlanta, Georgia, USA
• Update on Cardiovascular and Kidney Outcomes with SGLT2 Inhibitors. 
  Kolkatta, Cochin, Pune, New Delhi and Meerut, India - 1/29/2019
• Lessons from the CARMELINA Trial 
  UT Southwestern, Dallas, TX - 1/15/2019
• Update on Cardiovascular and Kidney Outcomes with SGLT2 Inhibitors 
  Texas Health Resources Presbyterian Hospital, Dallas, TX - 1/2/2019
• CV Outcomes Trials in Diabetes: Selected Lessons Learned thus Far 
  Multiple Locations, 2017, 2018, 2019 - 1/1/2019
• Assessment of Omega‐3 Carboxylic Acids in Statin Treated Patients with High Levels of Triglycerides and Low Levels of High Density Lipoprotein Cholesterol: Rationale a... 
  2nd International Congress on Abdominal Obesity, Buenos Aires, Argentina
• Evidence-based approaches to reducing premature cardiovascular mortality in patients with type 2 diabetes and established CV disease. 
  Munich, Germany - 1/25/2018
• The Future of Cardiovascular Outcomes Trials in Diabetes-Change course: We Need to Refocus Our Approach and Questions 
  Orlando, FL - 1/22/2018
• Uncertainties in Cardiometabolic Management: Heart Failure and Diabetes 
  Big Sky, MT - 1/21/2018
• Anti-hyperglycemic Agents and Atherosclerotic CV Disease: A Cardiologist�s Perspective 
  Atlanta, GA, 2018; Big Sky, MT, 2018 - 1/21/2018
• Introduction to Biostatistics 
  UT Southwestern, Dallas, TX, 2017, 2018 - 1/16/2018
• New Therapeutics in Diabetes: New Opportunity to Lower CV Risk 
  Dallas, TX - 1/12/2018
• Lessons of a Cardiodiabetologist 
  University of Toronto, Toronto, Ontario, Canada - 1/12/2018
• Heart Failure and Related Outcomes in the CARMELINA Trial 
  Chicago, IL - 1/11/2018
• Lessons Learned Thus Far from Cardiovascular Outcomes Trials in Diabetes: Cardiologist Perspective 
  University of Michigan, Ann Arbor, MI - 1/11/2018
• From Clinical Trials to Clinical Practice: Applying Cardiovascular Outcome Trial Data to T2DM Management 
  Chicago, IL - 1/9/2018
• Update on the SGLT2 inhibitor cardiovascular outcome trials 
  New Orleans, LA - 1/9/2018
• Type 2 Diabetes, CVD and Heart Failure: perspectives by a cardiologist 
  Aachen, Germany - 1/8/2018
• The Cardio-Diabetes Interface- where to next? 
  Brisbane, Australia; Sydney, Australia; Melbourne, Australia - 1/7/2018
• Join now to see all

Other

• The TECOS Trial of Sitagliptin vs. Placebo: Context and Cardiovascular Observations. 
  Gore MO, McGuire DK
  http://www.acc.org/latest-in-cardiology/articles/2015/11/20/14/19/the-tecos-trial-of-sitagliptin-vs-placebo
  1/23/2015
• MY APPROACH to Sulfonylureas in Patients With Coronary Artery Disease. 
  McGuire DK, Gore O, PracticeUpdate
  http://www.practiceupdate.com/ExpertOpinion/1088/1/8
  1/10/2014
• Consultant Live Podcast: DPP 4 Inhibitors 
  McGuire DK
  http://www.consultantlive.com/cardiovascular-diseases/content/article/10162/2129971
  1/27/2013
• Managing Diabetes and CAD Past, Present and Future: The Cardiologist�s Perspective 
  McGuire DK, Medscape Cardiology CME Webcast
  Amsterdam, The Netherlands - 1/2/2013
• Aspirin for Primary Prevention of Cardiovascular Events in People with Diabetes: The more we know, the more we don't know. 
  Gore MO, McGuire DK, American Heart Association Learning Library
  1/27/2010
• Lipid Management in Patients with Diabetes: LDL Lowering, Then What? 
  Khera A, McGuire DK, Cardiosource Web Site, American College of Cardiology Foundation
  1/4/2010
• Glucose Control in Acute Coronary Syndromes: Making a Hasty Retreat. 
  McGuire DK, Cardiosource Web Site, American College of Cardiology Foundation
  http://www.cardiosource.com/expertopinions/hottopics/article.asp?paperID=343
  1/15/2009
• Cardiovascular Effects of Sodium Glucose Co-transporter 2 (SGLT2) inhibitors: The Search for the How and Why. 
  Neeland IJ, De Albuquerque Rocha N, McGuire DK, Cardiosource, American College of Cardiology Foundation
• Join now to see all